US2005129709A1PendingUtilityA1
Method for enhancing stem cell trafficking
Priority: May 14, 2001Filed: Sep 20, 2004Published: Jun 16, 2005
Est. expiryMay 14, 2021(expired)· nominal 20-yr term from priority
A61P 9/10A61P 9/00A61P 43/00A61P 25/00A61P 25/16A61P 25/28A61P 1/16A61P 19/10A61K 35/748Y10S435/946A61P 21/00A61P 19/02
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Consumption of blue-green algae, or extracts thereof, enhances trafficking or homing of stem cells in animals by inducing a transient increase in the population of stem cells present in the animal's circulatory system. The animal may be healthy or suffering some disease or physiological condition.
Claims
exact text as granted — not AI-modified1 . A method for enhancing stem cell trafficking in a subject, comprising:
administering to the subject a therapeutically effective amount of a blue-green algae, or a component thereof, thereby enhancing stem cell trafficking.
2 . The method according to claim 1 where the subject is a mammal.
3 . The method according to claim 1 where the subject is a human.
4 . The method according to claim 1 where the blue-green algae is administered as dried whole cells.
5 . The method according to claim 1 where the blue-green algae is administered as a liquid fresh or frozen whole cells.
6 . The method according to claim 1 where the blue-green algae is Aphanizomenon flos aquae.
7 . The method according to claim 1 where the blue-green algae is a species of Spirulina.
8 . The method according to claim 1 where stem cell trafficking is increased by at least 200% as compared to a control.
9 . The method according to claim 8 where stem cell trafficking is increased about 100% to about 500% as compared to a control.
10 . The method according to claim 1 where the stem cell is a CD34+ cell.
11 . The method according to claim 1 where the subject has suffered a traumatic injury.
12 . The method according to claim 1 where the subject has a disease or physiological disorder.
13 . The method according to claim 12 where disease or physiological disorder is osteoporosis, Alzheimer's disease, cardiac infarction, Parkinson's disease, traumatic brain injury, multiple sclerosis, or cirrhosis of the liver.
14 . A method for enhancing stem homing in a subject, comprising:
administering to the subject a therapeutically effective amount of a blue-green algae, or a component thereof, thereby enhancing stem cell homing.
15 . The method according to claim 14 where the subject is a mammal.
16 . The method according to claim 14 where the subject is a human.
17 . The method according to claim 14 where the blue-green algae is administered as dried whole cells.
18 . The method according to claim 14 where the blue-green algae is Aphanizomenon flos aquae.
19 . The method according to claim 14 where stem cell homing is increased by at least 200% as compared to a control.
20 . The method according to claim 19 where stem cell homing is increased about 100% to about 500% as compared to a control.
21 . The method according to claim 14 where the stem cell is a CD34+ cell.
22 . A method of treating a subject with a disorder amenable to treatment with stem cells, comprising administering to the subject a therapeutically effective amount of a blue green algae or a component thereof.
23 . The method of claim 20 , wherein the subject has osteoporosis, Alzheimer's disease, cardiac infarction, Parkinson's disease, traumatic brain injury, multiple sclerosis, or cirrhosis of the liver.Join the waitlist — get patent alerts
Track US2005129709A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.